
Evista
Raloxifene tablets for postmenopausal osteoporosis and breast cancer. It mimics oestrogen in bone but opposes it in breast tissue.
- Categories
- Oncology Support · Bone Health
- Active ingredient
- Raloxifene
- Route
- Oral use
- Form
- Tablet
- Strengths
- 60mg
This listing uses Evista as a reference name. A generic equivalent is supplied; its exact brand and manufacturer are confirmed before supply.
Prescription and consultation requirements for Evista vary by destination and are determined by the fulfilment partner.
Evista details
- Conditions
- Postmenopausal Osteoporosis · Breast Cancer
- Alternative names
- raloxifene hydrochloride
- Therapeutic class
- Selective Oestrogen Receptor Modulator (SERM)
- Pharmacological class
- Oestrogen Agonist/Antagonist
- Contraindications
- history of venous thromboembolism; pregnancy; prolonged immobilisation
- Minor side effects
- hot flushes; leg cramps; headache
- Moderate side effects
- peripheral oedema; sweating; joint pain
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Originator
- Eli Lilly
- Onset Time
- 2–4 weeks
- Duration
- 24 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Cholestyramine; Warfarin; Oestrogens
- Age restrictions
- Approved for postmenopausal adult females.
Serious side effects
deep vein thrombosis, requires immediate medical attention; stroke, requires immediate medical attention
Patient summary
Raloxifene tablets for postmenopausal osteoporosis and breast cancer. It mimics oestrogen in bone but opposes it in breast tissue.
Mechanism of action
Acts as an oestrogen agonist on bone, keeping mineral density intact, but as an antagonist in breast tissue to limit cellular proliferation.
Pregnancy and breastfeeding
Pregnancy: Highly contraindicated. Risk of fetal anomalies. Breastfeeding: Contraindicated.
What you will receive
Evista is used here as a reference originator brand name to identify the medicine. We are not affiliated with the brand owner, and this listing does not offer the originator product.
- The supplied product is a generic equivalent containing Raloxifene, not the originator brand shown as the reference.
- The exact generic brand, manufacturer and dispatch location are confirmed based on the product, destination and available manufacturer or partner warehouse.
- Check the final product details at checkout before confirming an order.